Akcea Therapeutics and Ambry Genetics are partnering to offer no-cost, confidential genetic testing and confidential genetic counseling to patients through the hATTR Compass Genetic Testing Program who are clinically suspected of having hATTR amyloidosis with polyneuropathy as well as individuals with a family history of hATTR amyloidosis.
To highlight the urgency around early genetic testing, Akcea developed the hATTR Compass Genetic Testing Video Series. These videos feature physician and patient perspectives on the hATTR Compass Program and highlight other patient resources available through hATTR Compass, such as Backpack Health.
hATTR Compass Genetic Testing Video Series
hATTR Compass is designed to:
- Help accelerate or confirm the diagnosis of hATTR amyloidosis with polyneuropathy
- Provide support and resources to patients, caregivers and healthcare professionals throughout the genetic testing process
- Empower patients and their healthcare professionals to make the most informed decisions about their health care